Truehelm
Truehelm is a healthcare-focused private equity firm investing in healthcare IT and technology-enabled services.
- Healthcare and life sciences private equity investment firm
- Healthcare & Life Sciences PEF
- Tier III
Overview
Truehelm is a healthcare-focused private equity firm investing in healthcare IT and technology-enabled services. The firm adopted the Truehelm name in 2026 after operating as TT Capital Partners.
Its strategy centers on companies that improve how healthcare is delivered, managed, or financed through software, data, workflow tools, and specialized services. These businesses can benefit from strong industry demand but must demonstrate durable customer value, integration capability, and defensible market positioning. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.
Firm facts
| Institution | Truehelm |
| Type | Healthcare and life sciences private equity investment firm |
| Headquarters | Bloomington, United States |
| Founded | 2012 |
| Primary ranking focus | Healthcare & Life Sciences PEF |
| Highest 2026 tier | Tier III |
Activities and investment capabilities
Truehelm combines healthcare investment experience with operating and financial-services knowledge. Its focus is especially relevant as payers, providers, and other healthcare organizations seek more efficient administrative and clinical infrastructure.
Healthcare investing
Equity investment across healthcare services, products and technology.
Life sciences exposure
Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.
Sector value creation
Support informed by regulation, reimbursement, clinical workflows and market access.
Strategy and transaction coverage
Strategy and sector coverage
Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT
Transaction and ownership contexts
Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions
Market position
Truehelm fits Tier III because it is a focused, current, and institutionally developed health-tech investor with approximately $1 billion under management. Its narrower sector and transaction mandate distinguish it from broader healthcare private equity platforms.
Truehelm is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.
Competitive context
Truehelm is recognized Tier III in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Truehelm’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Truehelm as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Truehelm |
| Headquarters | Bloomington, United States |
| Public website | truehelm.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:
- The Mid-Market Advantage in Healthcare Private Equity
- Middle-Market Private Equity: Returns, Scale and Manager Selection
- Private Equity Technology Due Diligence in the AI Era
